Lv1
20 积分 2023-05-29 加入
From Venom‐to‐Vial‐to‐Pill: The Translational Journey of GLP‐1 Peptides and the Evolving Landscape of Biopharmaceutics Modeling
1个月前
已完结
Hydrogel Drug Delivery System Using Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide
2个月前
已完结
The chronic administration of two novel long‐acting Xenopus glucagon‐like peptide‐1 analogs xGLP159 and XGLP296 potently improved systemic metabolism and glycemic control in rodent models
3个月前
已完结
Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives
3个月前
已完结
Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP‐1, GIP, and Glucagon Agonists
5个月前
已完结
GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models
5个月前
已完结
Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes
6个月前
已完结
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice
7个月前
已完结
Small-Molecule FGFR-Targeted Medicinal Chemistry: Advances Since 2020 and Future Perspectives
11个月前
已完结
皖公网安备34019202002308
